{
    "Trade/Device Name(s)": [
        "A1CNow+",
        "A1CNow Self Check"
    ],
    "Submitter Information": "Bayer HealthCare Diabetes Care",
    "510(k) Number": "K090473",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051321"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "May 14, 2009",
    "Summary Letter Received Date": "April 15, 2009",
    "Submission Date": "April 14, 2009",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Percent Hemoglobin A1c (glycated hemoglobin)"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood",
        "Venous blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "A1CNow+ monitor"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "Kit",
        "Cartridge",
        "Sample preparation"
    ],
    "Document Summary": "FDA 510(k) summary for A1CNow+ and A1CNow Self Check devices for home and professional monitoring of glycated hemoglobin using whole blood samples",
    "Indications for Use Summary": "Quantitative measurement of percent glycated hemoglobin (%HbA1c) levels in whole blood samples for monitoring glycemic control in people with diabetes; intended for both home and professional use",
    "fda_folder": "Hematology"
}